We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 462

Parachuting off the patent cliff

  • Gilbert + Tobin
  • -
  • Australia
  • -
  • February 26 2015

Yesterday the Federal court handed down its decision in ACCC v Pfizer. The facts of the case reflect the very significant power of IP rights and the

ACCC pfails in section 46 prosecution in brief

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • February 25 2015

This morning the Federal Court handed down its decision in the misuse of market power proceedings against Pfizer, holding that the ACCC had failed to

Court rejects ACCC claim against Pfizer

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • February 25 2015

The Federal Court has today dismissed a case brought by the Australian Competition and Consumer Commission (ACCC) against Pfizer Australia for

The same but different: heading off generic market entry which does not patent infringe

  • Shelston IP
  • -
  • Australia
  • -
  • February 20 2015

A preliminary discovery application brought in the Federal Court of Australia by GlaxoSmithKline Australia Pty Ltd (GSK) shortly before Christmas has

High Court to consider gene patents: D’arcy granted leave to appeal

  • Davies Collison Cave
  • -
  • Australia
  • -
  • February 20 2015

On the 13 February 2015 the High Court of Australia granted special leave to appeal the decision of the Full Federal Court in D'Arcy v Myriad

So why did the High Court of Australia grant leave to reconsider the patentability of genetic sequences

  • Watermark Patent & Trade Marks Attorneys
  • -
  • Australia
  • -
  • February 20 2015

While considering the notions of staring down 'magic microscopes' PDF, 531KB and sniffing out DNA in test tubes, the High Court of Australia has

Australian High Court to hear appeal on gene patents

  • AJ Park
  • -
  • Australia
  • -
  • February 20 2015

Australia's highest court has granted Yvonne D'Arcy special leave to appeal the Full Federal Court's decision that isolated DNA is patentable subject

Drafting guidelines in light of S40(3) amendments

  • Spruson & Ferguson
  • -
  • Australia
  • -
  • February 19 2015

S40 of the Patents Act 1990 (Cth) is related to internal validity of a patent specification and, in essence, provides rules for drafting patent

Leave to appeal to the High Court granted in Myriad gene patent case

  • Fisher Adams Kelly
  • -
  • Australia
  • -
  • February 18 2015

The High Court of Australia has granted special leave to Yvonne D’Arcy to appeal the high profile Full Federal Court decision affirming the

Innovative arguments by innovator

  • Piper Alderman
  • -
  • Australia
  • -
  • February 18 2015

The Federal Court has ordered Pharmacor to provide preliminary discovery to GlaxoSmithKline Australia of evidence regarding Osteomol 665, a competitor